EDGAR Filing Documents for 0001193125-15-187272

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:

SEC Accession No. 0001193125-15-187272

Filing Date

2015-05-14

Accepted

2015-05-14 11:20:48

Documents

Period of Report

2015-03-31

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 10-Q	d918278d10q.htm	10-Q	253310
2	EX-31.1	d918278dex311.htm	EX-31.1	8290
3	EX-31.2	d918278dex312.htm	EX-31.2	8313
4	EX-32.1	d918278dex321.htm	EX-32.1	2505
5	EX-32.2	d918278dex322.htm	EX-32.2	2523
	Complete submission text file	0001193125-15-187272.txt		2718716

Data Files

Seq	Description	Document	Type	Size
6	XBRL INSTANCE DOCUMENT	pirs-20150331.xml	EX-101.INS	240895
7	XBRL TAXONOMY EXTENSION SCHEMA	pirs-20150331.xsd	EX-101.SCH	34302
8	XBRL TAXONOMY EXTENSION CALCULATION LINKBASE	pirs-20150331_cal.xml	EX-101.CAL	37957
9	XBRL TAXONOMY EXTENSION DEFINITION LINKBASE	pirs-20150331_def.xml	EX-101.DEF	110800
10	XBRL TAXONOMY EXTENSION LABEL LINKBASE	pirs-20150331_lab.xml	EX-101.LAB	291505
11	XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE	pirs-20150331_pre.xml	EX-101.PRE	188129

Mailing Address LISE-MEITNER-STRASSE 30 FREISING-WEIHENSTEPHAN 2M 85354

Business Address LISE-MEITNER-STRASSE 30 FREISING-WEIHENSTEPHAN 2M 85354 49 81 6114 11400

PIERIS PHARMACEUTICALS, INC. (Filer) CIK: 0001583648 (see all company filings)